| PERIOD ENDING | 31-May-09 | 28-Feb-09 | 30-Nov-08 | 31-Aug-08 | | Total Revenue | 3,161,000 | 4,035,000 | 2,649,000 | 1,899,000 | | Cost of Revenue | 1,327,000 | 1,514,000 | 1,099,000 | 975,000 | | | Gross Profit | 1,834,000 | 2,521,000 | 1,550,000 | 924,000 | | | Operating Expenses | | Research Development | 295,000 | 265,000 | 252,000 | 308,000 | | Selling General and Administrative | 504,000 | 522,000 | 550,000 | 695,000 | | Non Recurring |
-
| 162,000 |
-
| 161,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,035,000 | 1,572,000 | 748,000 | (240,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10,000 | (14,000) | (1,000) | 21,000 | | Earnings Before Interest And Taxes | 1,045,000 | 1,558,000 | 747,000 | (219,000) | | Interest Expense | 32,000 | 26,000 | 23,000 | 11,000 | | Income Before Tax | 1,013,000 | 1,532,000 | 724,000 | (230,000) | | Income Tax Expense | 308,000 | 440,000 | 176,000 | (48,000) | | Minority Interest | (11,000) | (1,000) | (2,000) | (7,000) | | | | Net Income From Continuing Ops | 694,000 | 1,091,000 | 546,000 | (189,000) | | | Non-recurring Events | | Discontinued Operations |
-
| 1,000 | 10,000 | 17,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 694,000 | 1,092,000 | 556,000 | (172,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $694,000 | $1,092,000 | $556,000 | ($172,000) |
|
0.45% Nasdaq 
0.20%
Income Statement
